OTC Tip Reporter releases next company we are covering and its Mydecine (OTC Stock Symbol MYCOF). This is my next stock that looks ready to move in a major way, so make sure you have it pulled up on your trading screen Monday morning at the opening bell.
Mydecine Innovations Group is a life sciences company dedicated to the development Mydecine experienced cross functional teams have the capabilities to oversee all areas of By leveraging strategic partnerships with scientific, medical, military, and clinical Their trailblazing portfolio of companies is focused on providing innovative and Mydecine Innovations Group Inc. is a parent company which operates innovative Mydecine Innovations Group Inc. operates a number of hemp-derived CBD and Mydecine Signs Partnership Agreement With Applied Pharmaceutical Innovation Mydecine Innovations Group Inc. announced the establishment of a research division The agreement with API provides exceptional capacity for Mydecine and the ability to SIGN UP FOR OTC TIP REPORTER NEWSLETTER The Faculty of Pharmacy and Pharmaceutical Sciences is consistently ranked in the top Mydecine is also able to access broader expertise through the agreement such as API’s Through the agreement, Mydecine has the ability to immediately commence fungal With access to GMP capacity and Health Canada licenses that include the ability to move “We see this agreement as a core component of our work as a company,” says Mydedine “Our partnership with the University of Alberta will unlock brand new avenues for the This research partnership opens up, not only investigation of single molecules from “Back to the fungal future,” Dr. Neal Davies, Dean, Faculty of Pharmacy and “We’re thrilled to be working with Mydecine,” says API CEO, Andrew MacIsaac, Mydecine Drops Bombshell Acquisition News Their Acquiring Mindleap Health’s MYCOF Just Released Blockbuster Acquisition News They Have Signed a Definitive Mindleap Health we are focused on positively impacting society through a disruptive Advanced Digital Telehealth Platform Technology Mindleap is a digital health platform that helps people connect with mental health The Mindleap platform will provide support for people that are looking to achieve Mental health has been a big issue and is a major focus for the Mydecine Group of Mydecine Director and CEO, Josh Bartch, stated: "This acquisition brings Mydecine an Mindleap is focused on making a considerable difference in people's lives by improving
The team of mental health professionals that led the product design at Mindleap comprise Mindleap's CTO Simon Abou-Antoun has 10+ years of technical leadership, managing Mindleap's founder and CEO Nikolai Vassev brings a unique skillset to the company as Nikolai Vassev, Mindleap Founder and CEO commented: "The intense anxiety and fear About Mydecine Innovations Group Mydecine Innovation's Group is a life sciences company focused on the development
About Mindleap Health Mindleap Health is developing an advanced digital telehealth platform that will provide Mindleap Health is at the forefront of this industry with its digital telehealth platform The tools Mindleap is building are the first of their kind to allow the patient to monitor, The system is completely secure and compliant with HIPAA and GDPR mandates and is Finally, Digital Mental Healthcare As a society, we are becoming more familiar with digital healthcare. Electronic medical Apropos, already valued at $31.46BIL in 2018, the global telemedicine market is Mindleap's comprehensive platform, expected to launch at the end of summer, includes Mindleap is also capitalizing on the world’s love of digital technologies, such as It is the epitome of the purpose of Big Data to anonymously help the greater cause by The market opportunity as a first mover is tremendous, to say the least. There are more To put this market opportunity into perspective, consider Livongo. The company has We're at a Tipping Point Thankfully, awareness is growing about the very real medicinal usefulness of psilocybin Leading research organizations, including Johns Hopkins, have dedicated millions of The next logical progression is providing patients with the best support possible to help Big Names are Investing in Psychedelics (Should You?) If you’re still on the fence about psychedelics, however, you need to know that there are Both Linton and O’Leary recently became heavy investors in Mind Medicine Inc., a Another name that should be familiar to investors is Peter Thiel, the Silicon Valley A major driving force in the psychedelics wave isn’t a name, however, it’s a government Leading research organizations, including Johns Hopkins, have dedicated millions of As the emerging sector sees more trials and investments, you can expect more big names |
Science based sustainable craft mushroom cultivation and genetic IP research and development Farms aims to be a pioneer in the cultivation and genetic IP development of mushrooms The Company will cultivate a variety of strains of mushroom and fungi that will be used |
Creating functional products for the future Mydecine Wellness is a revolutionary product developer and manufacturer of a variety of proprietary formulated nutraceutical and supplemental products based on the use of various strains of mushrooms and fungi. The Company will leverage its science, research, product development and marketing expertise to utilize the vast benefits of various compounds found within certain strains of mushroom and fungi found throughout the world. |
|
Unlocking the vast medical potential of psychedelics through public and private research and development Mydecine Labs will be a trailblazer in the research, development and discovery of groundbreaking IP derived from psychedelic compounds, namely psilocybin, found in various strains of mushroom and fungi. The Company intends to have a two-prong approach both public and private, leveraging its extensive science team as well as partnerships with pertinent departments of major universities. The Bottom Line... The Barchart Technical Opinion Rating Upgraded MYCOF Bullish 100% BUY Opinion Wall Streets leading provider of market data to the global financial, media, and commodity industries just issued MYCOF a bullish 100% BUY Rating Medium Term. I strongly suggest you click here and read the technicals immediately to learn why MYCOF could turn out to be another potential breakout gainer like my previous low float winners. It’s important to remember that historically, small-cap biotech, life sciences, nutraceutical and therapeutics companies have been our biggest winners that are cut from the same cloth as MYCOF. I am urging all of our subscribers to add MYCOF to the top of their watch list right now, and be ready Monday morning at the opening bell. To subscribe to OTC Tip Reporter Click Here About Us At OTCtipReporter.com our picks are built on a solid foundation through identifying chart patterns using technical analysis to provide the best trading opportunities for you. We analyze daily market activity and provide members with stock alerts daily. With that, OTC Tip Reporter wanted to determine a reliable and consistently profitable method of investing in Penny Stocks by entering trades at low risk points, with high upside intact. The methodology really revolves around understanding “herd” behavior as it applies to Penny Stock markets. Herd or crowd behavior is crucial to understand as it relates to investing in the Penny Stock markets in order to be successful. Elliott wave theory for example, is one of the foundations that OTC Tip Reporter fully understands and utilizes to some degree, after years of studying human behavioral patterns, Fibonacci retracements, and Elliott wave patterns. Investors love to chase stocks up and by doing so they increase their risk without knowing it. The crowd loves to sell low and buy high, OTC Tip Reporter prefers to do the opposite. This is why we stress “TIMING IS EVERYTHING” we don’t want you to miss a beat with any of our picks we present to you. This is why we want our members to get our Alert’s first, before the crowd. What if you could consistently buy just before the crowd jumps in and pushes a stock up rapidly? This all comes into play before a “Stock Alert” is delivered. Our goal is to provide you with the latest insights in the market with stocks that can make you huge profits. Contact Us You can call us toll free at: 1-800-850-9305 |
Improve Company Exposure and Visibility to Shareholders with NASDAQ and NYSE Investor Relations Packages from OTC Tip Reporter
Released On: 10/21/2021
Views: 1770
Increase Company Visibility to Shareholders with NASDAQ and NYSE Investor Relations Packages from OTC Tip Reporter
Released On: 10/17/2021
Views: 1668
Reach New and Potential Investors with Your Company News with OTC Tip Reporter Investor Relations Packages
Released On: 10/13/2021
Views: 1645
OTC Tip Reporter Offers Investor Relations Media Packages to NYSE and NASDAQ Trading Companies To Improve Visibility on The Exchanges
Released On: 10/8/2021
Views: 1493
Entrust in OTC Tip Reporter For Qualified Investor Relations Packages For Reaching New and Potential Shareholders with Your NASDAQ or NYSE Company News
Released On: 10/3/2021
Views: 1574
OTC Tip Reporter Works with NASDAQ and New York Stock Exchange Public Companies To Increase Online Presence with Customized Investor Relations Campaigns
Released On: 9/30/2021
Views: 1738
OTC Tip Reporter Is The Trusted Source for Digital Marketing Campaigns for Small Cap and Mid Size Publicly Traded Companies
Released On: 9/28/2021
Views: 1446
Reach Potential Shareholders and Investors with Company News with NASDAQ or NYSE Investor Relations Campaigns from OTC Tip Reporter
Released On: 9/26/2021
Views: 1715
OTC Tip Reporter Is The Leading Digital Media and Marketing Advertising Company Assisting Small Cap Companies with Increasing Brand Awareness and Visibility in the Investment Community
Released On: 9/25/2021
Views: 1411
Best Investor Relations Firm for NASDAQ and New York Stock Exchange Public Companies is OTC Tip Reporter
Released On: 9/22/2021
Views: 1471
Improve Corporate Visibility to Potential Investors with NASDAQ and NYSE Investor Relations Campaigns from OTC Tip Reporter
Released On: 9/17/2021
Views: 1786
Now Potential Shareholders and Investors Can Be Educated About Your Company with NASDAQ or NYSE Investor Relations Campaigns from OTC Tip Reporter
Released On: 9/8/2021
Views: 1286
When News of Your Company Lacks Visibility to Potential Shareholders, Call on The Experience of OTC Tip Reporter to Provide Targeted Media Campaigns
Released On: 9/4/2021
Views: 1251
OTC Tip Reporter Assists Companies Trading on The Exchanges with Improving Exposure of Pertinent Company News and Shareholder Information
Released On: 9/2/2021
Views: 1821
Rely on Customized Investor Relations Campaigns From OTC Tip Reporter For Reaching New and Potential Shareholders with Your NASDAQ or NYSE Corporate News
Released On: 8/31/2021
Views: 1683
OTC Tip Reporter Provides NASDAQ and NYSE Trading Companies Investor Relations Media Packages To Increase Company Visibility on The Exchanges
Released On: 8/30/2021
Views: 1437
OTC Tip Reporter Helps NASDAQ and NYSE Companies Reach Potential Investors with Investor Relations Packages
Released On: 8/29/2021
Views: 1433
Increase Company News Visibility to Potential Shareholders with NASDAQ and NYSE Investor Relations Packages from OTC Tip Reporter
Released On: 8/27/2021
Views: 1401